For example, gemcitabine, commonly used in the treatment of pancreatic cancer and non-small cell lung cancer, may cause cardiotoxicity as it reduces the expression of Kv11.1 (human rapid delayed rectifier potassium channel, hERG). Here, KCNH2 is linked to non-small cell lung carcinoma.